ADARx Pharmaceuticals, Inc.
NASDAQ:ADRXBiotechnology
+$0.13 today
- Market cap
- $1.42B
- Beta
- 0.00
Volume 0.65M
Average 1.06M
ADRX Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
Common Stock history
Currency unavailable · from the balance sheet
No Common Stock data reported for this period type.
Common Stock vs competitors
How ADRX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $1.63B USD | +37.9% | +26.3% | 278.8% | |
| Mar 2026 | $10.29M USD | +200.0% | +24.1% | 8.9% | |
| Mar 2026 | €4.31M EUR | -7.3% | +8.5% | 4.4% | |
| Mar 2026 | $28K USD | +3.7% | +1.2% | 0.0% | |
| Mar 2026 | $16K USD | — | — | 0.0% | |
| Mar 2026 | $6K USD | +20.0% | +7.7% | 0.0% | |
| Mar 2026 | $3K USD | +0.0% | +14.5% | 0.0% | |
| Mar 2026 | $3K USD | +50.0% | — | 0.0% | |
| Mar 2026 | $2K USD | +0.0% | +0.0% | 0.0% | |
ADRXADARx Pharmaceuticals, Inc. | — | — | — | — | — |
| Peer median (excluding ADRX) | — | +11.9% | +8.5% | 0.0% | |
Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
ADARx Pharmaceuticals, Inc.
NASDAQ:ADRX
Intrinsic Alpha fair value
Locked
Current Price
$12.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.